samedan logo

home > ict > autumn 2019 > learning to fish in data lakes
International Clinical Trials

Learning to Fish in Data Lakes

Today, clinical operations teams are drowning in data but starving for information, at a time of intense pressure to speed up clinical trials and restrain costs (1). The massive volumes of data generated during clinical trials are woefully inadequate at helping stakeholders spot risk factors and bottlenecks that can disrupt cycle times and budgets, primarily due to the inefficient ways in which operational data are captured and analysed, often relying on outdated methods such as Excel. Excel was not designed to collect and analyse clinical trial data as it lacks project management capability, yet its extensive use persists (2-3).

Having technology that can automate or assist in the timely monitoring of trials is a huge improvement over the current status quo of manual methods such as spreadsheets, which are cumbersome and erroneous, not to mention they only provide a dated view of trial performance.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the author

Craig Morgan is responsible for directing the global marketing strategy and team for the Oracle Health Sciences suite of study startup applications, working with sponsors, CROs, medical device manufacturers, and sites to reduce cycle times and improve collaboration and oversight in clinical trials. He is a technology and life science management professional with over 15 years’ experience in the application of informatics and bioinformatics to drug discovery, and eClinical technology associated with starting clinical trials. Craig holds degrees in Analytical Chemistry, Information Systems, and Business Administration and is a certified Project Manager with the Project Management Institute.
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals initiates partnership with American Biotech Zhittya for Parkinson’s disease treatment

3P and Zhittya began their relationship at the beginning of 2019 with 3P being selected as the CDMO to transfer the process for scaling up and performing cGMP manufacturing for clinical studies. After successfully achieving transfer of the process, 3P anticipates manufacturing of the first cGMP batch by the second quarter of 2020.
More info >>

White Papers

What is process characterization?


Process characterization is an essential step in the commercialization of a new (biological) drug. For drug product commercialization, manufacturers must validate the drug’s manufacturing process. This ensures that the manufacturing process delivers consistently a quality product and that the patient is not at risk.
More info >>

Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement